Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222

NCT04877743 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04877743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04877743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Terminated
Start date
May 31, 2021
Completion date
November 24, 2021
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019 (covid-19)